EPAD presented at AAIC2022

The Alzheimer’s Association International Conference is the largest and most influential international meeting dedicated to advancing dementia science. Each year, AAIC convenes the world’s leading basic science and clinical researchers, next-generation investigators, clinicians and the care research community to share research discoveries that’ll lead to methods of prevention and treatment and improvements in the diagnosis of Alzheimer’s disease. This year, the conference took place from 31st July to 4th August as a hybrid event (online and in San Diego, US) and attracted over 10,000 attendees.

We were pleased that several EPAD researchers presented their respective work at the Alzheimer’s Association International Conference:
– Sarah Gregory (UEDIN): “Does adherence to the Mediterranean diet have differential effects on brain health for those living within and outside of the Mediterranean region?” ORAL
– Luigi Lorenzini (VUmc): “Concerted alterations of functional connectivity and WM integrity in relationship to early amyloid deposition” POSTER
– Luigi Lorenzini (VUmc): “Functional eigenvector centrality dynamics are related to amyloid deposition in preclinical Alzheimer’s Disease.” POSTER
– Gonzalo Sánchez-Benavides (BBRC) “Re-examining the impact of adjusting for education and sex the RBANS delayed memory score: Implications on the cut-offs used to detect cognitive impairment in prodromal Alzheimer’s disease. Data from the EPAD-LCS study.” POSTER
– Irene Cumplido-Mayora (BBRC) “Biological Brain Age Prediction Using Machine Learning on Structural Neuroimaging Data: Multi-Cohort Validation Against Biomarkers of Alzheimer’s Disease and Neurodegeneration. POSTER

If you are interested to learn more about our dataset and samples, you can download the EPAD flyers that we distributed at the ADDI booth here.

In addition, winners of the ADDI NeuroToolKit (NTK) Data Hackathon have been anncounced live at ADDI’s symposium during the conference. The ADDI NTK Hackathon was a virtual event, bringing together researchers, biostatisticians, data scientists, and clinicians to investigate the potential clinical utility of different biomarkers in Alzheimer’s disease. Self-selected teams used a beta version of the NTKApp, EPAD datasets, and statistical analysis tools available on the AD Workbench. For more information, visit the ADDI website.

Save the date for the next Alzheimer’s Association International Conference to be held on 16-23 July 2023 in Amsterdam (Netherlands).